# B&G Foods, Inc.: overview

BGS · NYSE · CIK 1278027 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/bgs.md) · [Financials](/companies/bgs/financials.md) · [Filings](/companies/bgs/filings.md) · [Insiders](/companies/bgs/insiders.md)

Latest reported revenue: [$383.3m](/filings/0001104659-26-094525.md) for Q2 FY2026, three months to 2026-07-04, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-094525).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [461](/filings/0001104659-25-106992.md) | [552 d](/filings/0001104659-26-022961.md) | [425](/filings/0001104659-26-060227.md) | [424](/filings/0001104659-26-094525.md) | [439](/filings/0001104659-25-106992.md) | [540 d](/filings/0001104659-26-022961.md) | [409](/filings/0001104659-26-060227.md) | [383](/filings/0001104659-26-094525.md) |
| Gross margin | % | [22.2%](/filings/0001104659-25-106992.md) | [21.5% d](/filings/0001104659-26-022961.md) | [21.2%](/filings/0001104659-26-060227.md) | [20.5%](/filings/0001104659-26-094525.md) | [22.5%](/filings/0001104659-25-106992.md) | [22.7% d](/filings/0001104659-26-022961.md) | [19.5%](/filings/0001104659-26-060227.md) | [20.8%](/filings/0001104659-26-094525.md) |
| Operating margin | % | [11.1%](/filings/0001104659-25-106992.md) | [(46.6%) d](/filings/0001104659-26-022961.md) | [8.4%](/filings/0001104659-26-060227.md) | [5.2%](/filings/0001104659-26-094525.md) | [2.5%](/filings/0001104659-25-106992.md) | [5.2% d](/filings/0001104659-26-022961.md) | [(2.7%)](/filings/0001104659-26-060227.md) | [9.0%](/filings/0001104659-26-094525.md) |
| Net margin | % | [1.6%](/filings/0001104659-25-106992.md) | [(40.3%) d](/filings/0001104659-26-022961.md) | [0.2%](/filings/0001104659-26-094525.md) | [(2.3%)](/filings/0001104659-26-094525.md) | [(4.4%)](/filings/0001104659-25-106992.md) | [(2.8%) d](/filings/0001104659-26-022961.md) | [(8.0%)](/filings/0001104659-26-094525.md) | [(1.0%)](/filings/0001104659-26-094525.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001104659-25-106992.md) | not reported | [0.01](/filings/0001104659-26-060227.md) | [(0.12)](/filings/0001104659-26-094525.md) | [(0.24)](/filings/0001104659-25-106992.md) | not reported | [(0.41)](/filings/0001104659-26-060227.md) | [(0.05)](/filings/0001104659-26-094525.md) |
| Free cash flow | $m | [(0.7) d](/filings/0001104659-25-106992.md) | [71.7 d](/filings/0001104659-26-022961.md) | [42.4](/filings/0001104659-26-060227.md) | [11.5 d](/filings/0001104659-26-094525.md) | [(70.7) d](/filings/0001104659-25-106992.md) | [87.7 d](/filings/0001104659-26-022961.md) | [18.7](/filings/0001104659-26-060227.md) | [28.2 d](/filings/0001104659-26-094525.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-01) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2026-01-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,056](/filings/0001558370-24-001996.md) | [2,163](/filings/0001558370-25-001513.md) | [2,062](/filings/0001104659-26-022961.md) | [1,932](/filings/0001104659-26-022961.md) | [1,829](/filings/0001104659-26-022961.md) |
| Gross margin | % | [21.3%](/filings/0001558370-24-001996.md) | [18.9%](/filings/0001558370-25-001513.md) | [22.1%](/filings/0001104659-26-022961.md) | [21.8%](/filings/0001104659-26-022961.md) | [21.8%](/filings/0001104659-26-022961.md) |
| Operating margin | % | [9.5%](/filings/0001558370-24-001996.md) | [4.6%](/filings/0001558370-25-001513.md) | [3.9%](/filings/0001104659-26-022961.md) | [(9.2%)](/filings/0001104659-26-022961.md) | [5.3%](/filings/0001104659-26-022961.md) |
| Net margin | % | [3.3%](/filings/0001558370-24-001996.md) | [(0.5%)](/filings/0001558370-25-001513.md) | [(3.2%)](/filings/0001104659-26-022961.md) | [(13.0%)](/filings/0001104659-26-022961.md) | [(2.4%)](/filings/0001104659-26-022961.md) |
| Diluted EPS | $ per share | [1.02](/filings/0001558370-24-001996.md) | [(0.16)](/filings/0001558370-25-001513.md) | [(0.89)](/filings/0001104659-26-022961.md) | [(3.18)](/filings/0001104659-26-022961.md) | [(0.54)](/filings/0001104659-26-022961.md) |
| Free cash flow | $m | [50.3](/filings/0001558370-24-001996.md) | [(16.3)](/filings/0001558370-25-001513.md) | [222](/filings/0001104659-26-022961.md) | [104](/filings/0001104659-26-022961.md) | [70.7](/filings/0001104659-26-022961.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bgs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $24.7m | 6,206,181 |  | Reduced −398,104 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $15.1m | 3,797,413 |  | Reduced −689,661 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $13.8m | 3,456,171 |  | Added +43,964 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $11.9m | 2,993,289 |  | Added +1,317,400 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $10.2m | 2,565,830 |  | Reduced −628,065 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.4m | 2,109,327 |  | Added +211,799 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $7.3m | 1,787,165 |  | Added +7,421 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $7.1m | 1,784,312 |  | Reduced −711,582 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $6.7m | 1,687,409 |  | Added +30,846 |
| [Dana Investment Advisors, Inc.](/funds/1427514.md) | 2026-06-30 | $6.6m | 1,646,569 |  | Added +145,403 |

## Recent filings

[All 910 filings](/companies/bgs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 20:05 ET | [8-K](/filings/0001104659-26-115490.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115490 |
| 2026-10-06 | 12:00 ET | [8-K](/filings/0001104659-26-113896.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113896 |
| 2026-08-12 | 12:05 ET | [10-Q](/filings/0001104659-26-094525.md) | Quarterly report, period 2026-07-04 | 0001104659-26-094525 |
| 2026-08-11 | 21:00 ET | [8-K](/filings/0001104659-26-094128.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-094128 |
| 2026-08-11 | 20:05 ET | [8-K](/filings/0001104659-26-094042.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-094042 |
| 2026-06-10 | 20:05 ET | [8-K](/filings/0001104659-26-072323.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-072323 |
| 2026-06-04 | 20:59 ET | [8-K](/filings/0001104659-26-070572.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-070572 |
| 2026-06-01 | 15:55 ET | [8-K](/filings/0001104659-26-068744.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-068744 |
| 2026-06-01 | 15:52 ET | [8-K/A](/filings/0001104659-26-068743.md) | 9.01 Financial statements and exhibits | 0001104659-26-068743 |
| 2026-05-27 | 20:05 ET | [8-K](/filings/0001104659-26-066912.md) | 5.07 Shareholder vote results | 0001104659-26-066912 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 3, 2026](/filings/0001104659-26-022961.md), filed Mar 3, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1278027
- Tickers: BGS
- Exchange: NYSE
- SIC code: 2000 Food and Kindred Products
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.